Acrylamide

Agent Name
Acrylamide
CAS Number
79-06-1
Formula
C3-H5-N-O
Major Category
Plastics & Rubber
Acrylamide formula graphical representation
Synonyms
Acrylamide monomer; Acrylic amide; Propenamide; 2-Propenamide; [NIOSH]
Category
Other Monomers
Description
White crystalline, odorless solid; [NIOSH]
Sources/Uses
Used as a polymer or copolymer to produce sealants, adhesives, fibers, paper sizing, molded parts, water coagulants, and textiles. "In the United States, 90% of acrylamide is used to produce polyacrylamide for water treatment (60%), pulp and paper production (20%) and mineral processing (10%);" [ACGIH]
Comments
Can cause sensorimotor neuropathy after occupational exposure; "Polyacrylamide, with less than 0.01% acrylamide, is nontoxic and considered safe as a cosmetic ingredient. . . . Available data indicate no unique sensitivity to the fetus. . . . Most cases of acrylamide poisoning in humans involved exposures over weeks or months from handling the monomer in the course of polymerization. . . . Kim et al. (2017) reported two cases of dermal and neural toxicity in Korean grouting workers with exposure to grouting agents that contained a high concentration of acrylamide (32 and 39% monomer)." [ACGIH] Allergic contact dermatitis reported in laboratory workers using polyacrylamide gels for electrophoresis; [Kanerva, p. 1738] "Germ cell mutagens that have shown to increase the mutant frequency in the progeny of exposed mammals." [MAK] Acrylamide (UN2074) has warning of explosive polymerization; [ERG 2016]
Biomedical References

Exposure Assessment

BEI
N-(2-Carbamoylethyl)valine (CbEv) in blood (not critical); BEI = 500 pmo/g globin (After 120 days of representative work/exposure to Acrylamide); S-(2-Carbamoylethyl)mercapturic acid (AAMA) in urine (end of shift); BEI = 800 ug/g creatine.
Skin Designation (ACGIH)
Yes
TLV (ACGIH)
0.03 mg/m3, inhalable fraction and vapor
PEL (OSHA)
0.3 mg/m3
IDLH (NIOSH)
60 mg/m3
Excerpts from Documentation for IDLHs
Calculations based on an oral LD50 of 150 to 180 mg/kg for guinea pigs, rabbits, and rats [McCollister et al. 1964] indicate that a worker should be able to escape within 30 minutes without injury or irreversible health effects from 600 mg/m3. . . . the revised IDLH for acrylamide is 60 mg/m3 based on being 2,000 times the OSHA PEL of 0.03 mg/m3 that was promulgated in 1989 (2,000 is an assigned protection factor for respirators; only the most reliable respirators are recommended above 2,000 times the OSHA PEL). [Note: NIOSH recommends as part of its carcinogen policy that the "most protective" respirators be worn for acrylamide at concentrations above 0.03 mg/m3.]
Vapor Pressure
0.007 mm Hg
Explosive Polymerization
Yes
Explanatory Notes
VP from HSDB;
Half Life
Plasma (animal studies): 2 days; whole body (animal studies): 6-18 days; [TDR, p. 40]
NFPA
high ambient temp required

Adverse Effects

Skin Sensitizer
Yes
Neurotoxin
Sensorimotor
IARC Carcinogen
Probable (2a)
NTP Carcinogen
Anticipated human carcinogen
ACGIH Carcinogen
Suspected Human

Diseases, Processes, and Activities Linked to This Agent

Diseases

Occupational diseases associated with exposure to this agent: